| dc.contributor.author | Gullick, D.R. | |
| dc.contributor.author | Ingram, M.J. | |
| dc.contributor.author | Pugh, W.J. | |
| dc.contributor.author | Cox, P.A. | |
| dc.contributor.author | Gard, P. | |
| dc.contributor.author | Smart, J.D. | |
| dc.contributor.author | Moss, G.P. | |
| dc.date.accessioned | 2010-09-23T08:56:48Z | |
| dc.date.available | 2010-09-23T08:56:48Z | |
| dc.date.issued | 2009 | |
| dc.identifier.citation | Gullick , D R , Ingram , M J , Pugh , W J , Cox , P A , Gard , P , Smart , J D & Moss , G P 2009 , ' Metabolism of captopril carboxyl ester derivatives for percutaneous absorption ' , Journal of Pharmacy and Pharmacology , vol. 61 , no. 2 , pp. 159-165 . https://doi.org/10.1211/jpp/61.02.0004 | |
| dc.identifier.issn | 0022-3573 | |
| dc.identifier.other | dspace: 2299/4840 | |
| dc.identifier.uri | http://hdl.handle.net/2299/4840 | |
| dc.description | Original article can be found at: http://www.medicinescomplete.com/journals/jpp/current/ Copyright Pharmaceutical Press [Full text of this article is not available in the UHRA] | |
| dc.description.abstract | To determine the metabolism of captopril n-carboxyl derivatives and how this may impact on their use as transdermal prodrugs. The pharmacological activity of the ester derivatives was also characterised in order to compare the angiotensin converting enzyme inhibitory potency of the derivatives compared with the parent drug, captopril. | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Journal of Pharmacy and Pharmacology | |
| dc.title | Metabolism of captopril carboxyl ester derivatives for percutaneous absorption | en |
| dc.contributor.institution | Department of Pharmacy | |
| dc.description.status | Peer reviewed | |
| rioxxterms.versionofrecord | 10.1211/jpp/61.02.0004 | |
| rioxxterms.type | Journal Article/Review | |
| herts.preservation.rarelyaccessed | true | |
